STAT3 is required but not sufficient for EGF receptor-mediated migration and invasion of human prostate carcinoma cell lines
Authors:
Open Access
- 27 June 2006
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 95 (2) , 164-171
Abstract
Growth factor-induced migration is a rate-limiting step in tumour invasiveness. The molecules that regulate this cellular behaviour would represent novel targets for limiting tumour cell progression. Epidermal growth factor (EGF) receptor (EGFR)-mediated motility, present in both autocrine and paracrine modes in prostate carcinomas, requires de novo transcription to persist over times greater than a few hours. Therefore, we sought to define specific signalling pathways that directly alter cellular transcription. Signal transducer and activator of transcription 3 (STAT3) is activated, as determined by electrophoretic motility shift assays, by EGFR in DU145 and PC3 human prostate carcinoma cells in addition to the motility model NR6 fibroblast cell line. Inhibition of STAT3 activity by antisense or siRNA downregulation or expression of a dominant-negative construct limited cell motility as determined by an in vitro wound healing assay and invasiveness through a extracellular matrix barrier. The expression of constitutively activated STAT3 did not increase the migration, which indicates that STAT3 is necessary but not sufficient for EGFR-mediated migration. These findings suggest that STAT3 signalling may be a new target for limiting prostate tumour cell invasion. In a microarray gene analysis of what transcription units are altered by EGF in a STAT3-dependent manner we found that the expression of motility-limiting VASP protein and the apoptosis nexus caspase 3 were both downregulated upon EGF exposure. These findings suggest a molecular basis for the STAT3 dependence of EGFR-mediated prostate tumour progression.Keywords
This publication has 48 references indexed in Scilit:
- Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor In vivoClinical Cancer Research, 2005
- Localization of all seven messenger RNAs for the actin-polymerization nucleator Arp2/3 complex in the protrusions of fibroblastsJournal of Cell Science, 2005
- RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cellsThe Prostate, 2004
- Expression of a naturally occurring constitutively active variant of the epidermal growth factor receptor in mouse fibroblasts increases motilityInternational Journal of Cancer, 2003
- STATs in oncogenesisOncogene, 2000
- STAT signaling in head and neck cancerOncogene, 2000
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement.Journal of Cell Biology, 1994
- Effects of Epidermal Growth Factor on Invasiveness through the Extracellular Matrix in High‐ and Low‐metastatic Clones of RCT Sarcoma in vitroJapanese Journal of Cancer Research, 1994
- Ligand-Induced Transformation by a Noninternalizing Epidermal Growth Factor ReceptorScience, 1990